Mave Health Raises $2.1 Million in Initial Funding Round

Neurotech firm Mave Health has nabbed $2.1 million in seed funding led by Blume Ventures and backing from other funds and angel investors, including Stanford Angels, Dhaval Shroff, and Raymond Russell. The company recently launched a non-invasive wearable headset designed to improve focus, elevate mood, and regulate stress in 20 minutes a day.

Mave debuted with more than 500 beta customers ahead of its public release earlier this year. Based on self-reported data collected after four weeks of use:

• 80% of users reported productivity gains exceeding 60%
• Users reported an average mood improvement of 77%
• 75% reported stress reductions above 50%

The wearable headset supports daily mental health and cognitive performance. Its underlying technology, transcranial direct current stimulation (tDCS), has been studied for 25-plus years, with more than 10,000 published papers globally. tDCS has demonstrated an excellent safety profile and is well-suited for at-home use, according to the company. Mave Health packages this science into a lightweight, consumer-friendly device.

“The brain is the most complex system we rely on every day, and modern life is constantly overloading it. We expect it to perform at peak levels without giving it the support it needs,” Mave Health Co-Founder/CEO Dhawal Jain said. “Instead of chasing short-term boosts that come with long-term costs, we believe in strengthening the underlying systems that drive focus, mood, and stress regulation. Our approach is to use neurotechnology that is proven to be safe, effective, and easy to use.”

Mave Health’s headset delivers low-intensity electrical stimulation to strengthen the prefrontal cortex— the brain region associated with attention, emotional regulation, and stress response. Users wear the device for 20 minutes a day while working, reading, meditating, or going about their routine. There is no learning curve and no active effort required.

Most people report noticeable improvements within 15 to 20 days, with benefits compounding over time. The companion app allows users to log sessions, personalize protocols, and track progress without collecting any brain data.

The headset weighs 100 grams and lasts up to one month on a single charge with regular use. Each stimulation session lasts 20 minutes and uses an intensity of 1-2 mA, targeting the prefrontal cortex. The headset does not collect brain data or require ongoing internet connectivity. The companion app can sync with popular fitness wearables to help users track correlations with sleep quality, heart rate variability, resting heart rate, and other related metrics.

“Most of us only think about mental health when something goes wrong,” Jain commented. “That is why my co-founders Jai Sharma, Aman Kumar, and I started Mave. We are giving people the ability to regain control over their focus, energy, and clarity so they can perform at their best and live more fully every day.”

Mave Health develops non-invasive wearable headsets to help people improve focus, mood, and stress regulation. The product uses transcranial direct current stimulation (tDCS) to strengthen the prefrontal cortex in 20-minute daily sessions. Mave Health is a San Francisco and Bengaluru-based neurotechnology company founded in 2023.